Yuki Enoki
Impact in
- Nephrology top 2%
- Dialysis and Renal Disease Management
Papers in
-
- Antimicrobial Resistance in Staphylococcus 17
- Epidemiology 31
- Pneumonia and Respiratory Infections 9
- Co-authors
- Hiroshi Watanabe (13 shared papers)Kazuaki Matsumoto (88 shared papers)Kazuaki Taguchi (82 shared papers)Toru Maruyama (8 shared papers)Masaki Otagiri (17 shared papers)Yu Ishima (9 shared papers)Masafumi Fukagawa (8 shared papers)Motoko Tanaka (7 shared papers)
- Journals
- Biological and Pharmaceutical Bulletin (8 papers)Pharmaceutical Research (8 papers)Journal of Antimicrobial Chemotherapy (4 papers)Journal of Controlled Release (3 papers)Toxicology and Applied Pharmacology (3 papers)
- Partner nations
- JapanAustraliaUnited Kingdom
In The Last Decade
Yuki Enoki
90 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 110
- Nephrology 238
- Applied Microbiology and Biotechnology 53
- Clinical Biochemistry 118
- Infectious Diseases 284
- Molecular Medicine 68
Countries citing papers authored by Yuki Enoki
This map shows the geographic impact of Yuki Enoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuki Enoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuki Enoki more than expected).
Fields of papers citing papers by Yuki Enoki
This network shows the impact of papers produced by Yuki Enoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuki Enoki. The network helps show where Yuki Enoki may publish in the future.
Co-authors
The 25 scholars most cited alongside Yuki Enoki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 100 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 146 | |
| 2 | 2017 | 120 | |
| 3 | 2021 | 101 | |
| 4 | 2019 | 85 | |
| 5 | 2014 | 69 | |
| 6 | 2016 | 40 | |
| 7 | 2019 | 37 | |
| 8 | 2021 | 33 | |
| 9 | 2015 | 31 | |
| 10 | 2020 | 27 | |
| 11 | 2020 | 27 | |
| 12 | 2018 | 26 | |
| 13 | 2018 | 23 | |
| 14 | 2014 | 21 | |
| 15 | 2017 | 21 | |
| 16 | 2019 | 20 | |
| 17 | 2018 | 19 | |
| 18 | 2022 | 17 | |
| 19 | 2021 | 17 | |
| 20 | 2020 | 16 |
About Yuki Enoki
Yuki Enoki is a scholar working on Infectious Diseases, Epidemiology, Molecular Biology, Pharmacology and Surgery, having authored 100 papers that have together received 1.3k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (24 papers), Antimicrobial Resistance in Staphylococcus (17 papers), Heme Oxygenase-1 and Carbon Monoxide (13 papers), Neonatal Health and Biochemistry (11 papers), Bacterial Identification and Susceptibility Testing (10 papers), Hemoglobin structure and function (10 papers), Antibiotic Resistance in Bacteria (10 papers) and Pneumonia and Respiratory Infections (9 papers). The work is most often cited by research in Nephrology (238 citations), Applied Microbiology and Biotechnology (53 citations), Clinical Biochemistry (118 citations), Infectious Diseases (284 citations) and Molecular Medicine (68 citations). Yuki Enoki has collaborated with scholars based in Japan, Australia and United Kingdom. Frequent co-authors include Hiroshi Watanabe, Kazuaki Matsumoto, Kazuaki Taguchi, Toru Maruyama, Masaki Otagiri, Yu Ishima, Masafumi Fukagawa, Motoko Tanaka, Kazutaka Matsushita and Tadashi Imafuku. Their work appears in journals such as Biological and Pharmaceutical Bulletin, Pharmaceutical Research, Journal of Antimicrobial Chemotherapy, Journal of Controlled Release and Toxicology and Applied Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.